Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12139528
Treating refractory migraine
granted -
US 12139543
Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR
granted -
US 12128092
Lyophilized factor IX formulations
granted -
US 12129476
Methods for measuring the potency of AADC viral vectors
granted -
US 12121567
Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase
granted -
US 12116606
Complement factor I-related compositions and methods
granted -
US 12115166
Corticotropin releasing factor receptor antagonists
granted -
US 12104163
Adeno-associated virus vectors for treatment of Rett syndrome
granted -
US 12091675
Gene therapy of hemophilia a using viral vectors encoding recombinant FVIII variants with increased expression
granted -
US 12077506
Indane derivatives as hypoxia inducible factor-2(α) inhibitors
granted -
US 12077772
Transgene cassettes, AAV vectors and AAV viral vectors for the expression of human codon-optimized SLC6A1
granted -
US 12071632
Chimeric vectors
granted -
US 12071468
Purification of Factor VIII subspecies
granted -
US 12068729
Anti-factor XII/XIIa antibodies and uses thereof
granted -
US 12060566
Self-inactivating lentiviral vector comprising a FOXP3 expression cassette
granted -
US 12054517
Myeloid differentiation factor 2 (MD2) signaling and modulation
granted -
US 12049630
Factor XII (F12) iRNA compositions and methods of use thereof
granted -
US 12016932
Gene editing for hemophilia A with improved factor VIII expression
granted -
US 12018259
Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
granted -
US 12018261
Compounds and methods for modulating factor XII
granted -
US 12018027
Macrocyclic derivatives acting as XIa factor inhibitor
granted -
US 12012438
Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use
granted -
US 12006355
Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)
granted -
US 2024166750
GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTION
granted